Tagged Articles

testosterone therapy 38 articles

direct-to-consumer advertising likely increases testosterone treatment sales

The U.S. and New Zealand are the only countries in the world that allow drug companies to advertise directly to consumers. A new study published in the Journal of the American Medical Association (JAMA) shows just how powerful that opportunity is for Big Pharma. Direct-to-consumer advertising in the U.S. increased substantially from 2009 to 2013. The study focused on the marketing of testosterone replacement therapies, the biggest selling product being AndroGel manufactured by AbbVie. Testosterone therapy is intended for men with hypogonadism, a condition in which the body does not produce enough of the male hormone due to defect or ... Read More

Study suggests testosterone no better than skin cream at improving sex drive

Men age 65 and older who use testosterone replacement therapies enjoyed a microscopic short-term boost in libido but, in the long term, that improvement waned, according to a new study published in the New England Journal of Medicine. Testosterone replacement treatments are designed to boost levels of the male hormone in men with hypogonadism, a condition in which men produce too little testosterone due to injury or disease. As a man ages, his testosterone level naturally decreases. Testosterone treatments are not designed for men with age-related hypogonadism. Aggressive marketing campaigns waged by testosterone manufacturers have led to a boom in ... Read More

Testosterone therapy makers face thousands of lawsuits

Steve Schabel, a married father of three, said he began testosterone therapy in 2013 to treat depression and boost his sex drive. He started with the gel and then switched to an injection. A week later, he was hospitalized with a life threatening double pulmonary embolism, or blood clots in the lungs. Shabel had no prior history of heart problems. He has recovered but must take blood thinners for the rest of his life. He is now one of several men who is suing the manufacturer of his testosterone replacement treatment claiming the company engaged in questionable marketing practices to ... Read More

Dallas Cowboys linebacker suspended after drug test reveals testosterone use

Little-known Dallas Cowboys offensive lineman R.J. Dill is making headlines in recent weeks, but not for making big plays. Dill was suspended for the first four games of the season after he tested positive for testosterone replacement treatments. Dill claims he was prescribed testosterone for medical reasons, and that he only started using the hormone after he failed to make a roster last year and had assumed his career was over. But that doesn’t matter to the National Football League (NFL), whose strict performance-enhancing drug-testing policy bans use of the hormone except in extraordinary circumstances, such as a player whose ... Read More

Testosterone treatments overprescribed to some, under prescribed to others

Aggressive marketing campaigns waged by makers of testosterone treatments have catapulted sales of the drugs in the United States, and overuse among men who do not actually have low testosterone. A new study indicates that many men who do have a medical condition that causes low testosterone – men for whom testosterone treatments are designed – may not be using the drugs. The study, published in the journal Urology, involved records of all 9,176 men ages 18 to 85 who got their serum total testosterone levels checked at NorthShore University Health System in Chicago between 2009 and 2012. While testosterone levels ... Read More

New Jersey man blames heart attack on Axiron testosterone treatment

New Jersey resident Patrick Miller was 54 when he started using Axiron, a testosterone replacement product used to treat men who have low levels of the hormone in their blood. A month later, on Oct. 3, 2012, he had a heart attack. Thirteen months later, the Journal of the American Medical Association (JAMA) published a study that found men who used testosterone treatments have a 30 percent increased risk of having a heart attack, stroke or dying. And, in January 2014, the journal PLOS One found a two-fold increased risk of heart attack among older men in the first 90 days ... Read More

Experts: testosterone treatments vastly overprescribed

Nearly 3 percent of American men aged 40 and older – about two million men – received prescriptions for testosterone replacement treatments in 2011 – three times more than a decade earlier, raising concerns that the drugs may be overprescribed. Testosterone therapy is intended for men who suffer from low testosterone levels, a condition known as hypogonadism, caused by damage or disease in their testes or other parts of the endocrine system. This can cause symptoms such as low sex drive, muscle loss, weight gain and fatigue. Testosterone levels typically drop as a man ages. But many middle-aged and older ... Read More

Experimental testosterone therapy outperforms leading testosterone gel in studies

The experimental testosterone treatment Androxal performed better than a leading testosterone gel and placebo in the first of two studies, Repros Therapeutics Inc. announced. Data from the clinical trials showed that men treated with Androxal had more sperm concentration compared to men who were treated with AndroGel testosterone supplement. Androxal is being developed as an oral therapy to boost testosterone levels in men of reproductive age. Androxal a single isomer of clomiphene citrate, a drug currently marketed as Clomid to induce ovulation in women. It has been used off-label as a treatment for secondary low testosterone in men though, until ... Read More

Testosterone levels tend to fluctuate significantly in younger men but remain more constant in older men

Most schools of thought suggest that measuring testosterone levels in men can be tricky because the hormone levels vary from day to day as well as hour to hour. However, a new study finds that only young men experience statistically and clinically significant fluctuations in testosterone levels. Researchers studied records of more than 2,500 men ages 26 to 84 who had their testosterone levels checked at an erectile dysfunction clinic. The men were sorted into five age groups, beginning with 26- to 39-year-olds. Each of those groups were divided into sub-groups depending on the time of day their testosterone was ... Read More

Testosterone therapy does not appear to work in obese men with type 2 diabetes

Testosterone replacement therapy is designed to treat symptoms of “Low T,” such as low libido, weight gain, and fatigue; however, the treatment doesn’t appear to work on aging, obese men with type 2 diabetes, a new study shows. The new study published in The Journal of Clinical Endocrinology & Metabolism, found that testosterone supplements do not improve erectile dysfunction or general health in this population because testosterone levels are not the only issue causing their symptoms. The findings raise even more question about the controversial hormone supplements. Prescriptions for testosterone therapies, such as the widely used Androgel, Axiron and Testim, have skyrocketed ... Read More